Total Funding
42
54
Total FundingPost-IPO Equity raised
Growth Score
-1 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
74490
Eledon Pharmaceuticals is a biotechnology company developing treatments for people undergoing organ or cellular transplantation.
- Catherine C. Turkel: PresidentPast Role: Otic Pharma, Chief Development Officer
- Gregory Flesher: Chief Executive OfficerPast Role: Otic Pharma, Chief Executive Officer
About the Company
Eledon Pharmaceuticals is a clinical-stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation and for people with autoimmune and neurodegenerative diseases.
